TCHP and urinary bladder carcinoma: The proteomics and confirmation results demonstrated that PEPE2 treatment could increase PTP1B expression, and thus, the JAK/STAT3 pathway was inhibited in bladder cancer cells, implying that PTP1B might be a tumor suppressor protein in UBUC.